The Latest Breaking News from AstraZeneca

The pharmaceutical giant claimed the Labour Government failed to match Tory predecessor’s offer of help for its investment in Merseyside

The pharmaceutical giant claimed the Labour Government failed to match its predecessor’s offer but the cancelled project is a blow to the chancellor’s growth agenda

Massachusetts-based company is working on new treatments for gastrointestinal cancers

The city has a long history with tropical medicine and is now home to one of the largest biotech clusters in Europe

About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression outcomes in treated patients.

AstraZeneca appoints Iskra Reic as new head of China operations amid investigations and challenges in the pharmaceutical industry in China.

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone.

Here's why Eli Lilly, Pfizer, and AstraZeneca are biotech stocks worth considering, with strong pipelines and growth potential beyond vaccines.